Goldman Sachs
GMED icon

Goldman Sachs’s Globus Medical GMED Stock Holding History

Goldman Sachs’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,000
Closed -$1.07M – 6132
2024
Q3 		$1.07M Buy
+15,000
New +$1.06M ﹤0.01% 4587
2016
Q2 		– Sell
-55,500
Closed -$1.32M – 7107
2016
Q1 		$1.32M Buy
+55,500
New +$1.36M ﹤0.01% 3836

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's GMED Position: Q1 2026 in Review

Goldman Sachs increased its Globus Medical (GMED) stake by 54% in Q1 2026, buying an estimated $35.7M and bringing the position to 1,132,162 shares worth $97.5M. The position accounts for 0.01% of the portfolio, ranked #1045.

Goldman Sachs first reported a position in GMED in Q2 2013 and has held it in 52 quarters since. The position peaked at $132M in Q2 2013. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Goldman Sachs held 1,132,162 shares of Globus Medical worth $97.5M as of Q1 2026.
  • Goldman Sachs bought 397,561 Globus Medical shares in Q1 2026, an estimated $35.7M.
  • Globus Medical made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1045 holding.
  • Goldman Sachs first reported a position in Globus Medical in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Globus Medical position peaked at $132M in Q2 2013.
  • 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.